291 related articles for article (PubMed ID: 31908156)
1. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter
Jin L; Fan WH; Luan Y; Wu M; Zhao W
PeerJ; 2021; 9():e11366. PubMed ID: 33987029
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of therapeutic efficacy with CytoSorter
Zheng W; Zhang Y; Guo L; Wang S; Fang M; Mao W; Lou J
Cancer Manag Res; 2019; 11():5857-5869. PubMed ID: 31303792
[No Abstract] [Full Text] [Related]
5. Predictive Value of Circulating Tumor Cells for Evaluating Short- and Long-Term Efficacy of Chemotherapy for Breast Cancer.
Ma S; Ling F; Gui A; Chen S; Sun Y; Li Z
Med Sci Monit; 2017 Oct; 23():4808-4816. PubMed ID: 28986517
[TBL] [Abstract][Full Text] [Related]
6. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
7. Value of peripheral blood circulating tumor cell detection in the diagnosis of thoracic diseases and the prediction of severity.
Qi C; Xiong XZ
Clin Exp Med; 2023 Oct; 23(6):2331-2339. PubMed ID: 36929453
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive comparison of circulating tumor cells and breast imaging modalities as screening tools for breast cancer in Chinese women.
Shao X; Jin X; Chen Z; Zhang Z; Chen W; Jiang J; Wang Z; Cui Y; Fan WH; Wang K; Yu X; Huang J
Front Oncol; 2022; 12():890248. PubMed ID: 35978805
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer.
Xie X; Wang L; Wang X; Fan WH; Qin Y; Lin X; Xie Z; Liu M; Ouyang M; Li S; Zhou C
Front Oncol; 2021; 11():672687. PubMed ID: 34055642
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma.
Choi MK; Kim GH; I H; Park SJ; Lee MW; Lee BE; Park DY; Cho YK
J Gastroenterol Hepatol; 2019 Mar; 34(3):552-560. PubMed ID: 30426559
[TBL] [Abstract][Full Text] [Related]
11. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic yield of primary circulating tumor cells in women suspected of breast cancer: the BEST (Breast Early Screening Test) study.
Murray NP; Miranda R; Ruiz A; Droguett E
Asian Pac J Cancer Prev; 2015; 16(5):1929-34. PubMed ID: 25773847
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of circulating tumor cell numbers improves tracking metastatic breast cancer progression.
Szostakowska-Rodzos M; Fabisiewicz A; Wakula M; Tabor S; Szafron L; Jagiello-Gruszfeld A; Grzybowska EA
Sci Rep; 2024 Jun; 14(1):12924. PubMed ID: 38839863
[TBL] [Abstract][Full Text] [Related]
15. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and heterogeneity of circulating tumor cells in breast cancer.
Jakabova A; Bielcikova Z; Pospisilova E; Matkowski R; Szynglarewicz B; Staszek-Szewczyk U; Zemanova M; Petruzelka L; Eliasova P; Kolostova K; Bobek V
Breast Cancer Res Treat; 2017 Dec; 166(3):695-700. PubMed ID: 28815327
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.
Ren C; Han C; Fu D; Wang D; Chen H; Chen Y; Shen M
Int J Cancer; 2016 Apr; 138(7):1586-600. PubMed ID: 26178386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
